Inspections, Compliance, Enforcement, and Criminal Investigations
Agroaltos, S.A. 21-Aug-01
DEPARTMENT OF HEALTH & HUMAN SERVICES555 Winderley Pl, Suite 200
Maitland, FI 32751
VIA FEDERAL EXPRESS
Ref Customs Entry No:
XXX(-0034830-1 (Formerly AU1-0050628-7)
Product: Fresh Snow Peas
Estuardo Castro, Owner
c/o Hellman Perishables Logistics
10450 N.W. 41st Street
Miami, Florida 33179
Dear Mr. Castro:
The Food and Drug Administration (FDA), on April 27,2001, May 22,2001, June 22, 2001, and July 13, 2001, attempted to supervise the destruction of the above refused entries of snow peas which were offered for entry into the Untied States (U. S.) by your firm. The following chart gives background information for each of these entries:
Date Refusal Notice (RN)
Entry No. Entry Date Quantities Redeliver Demand (RD)
AU1-0049930-1 02/22/01 [redacted] cases 03/30/01 (RD)
AU1-0050062-9 02/26/01 [redacted] cases 03/17/01 (RN)
AU1-0050446-4 03/12/01 [redacted] cases 03/19/01 (RN)
AU1-0050628-7 03/19/01 [redacted] cases 04/30 & 7/16/01 (RD & RN)
(XXX-0034830-1) (Partial Refusal)
Review of entry documents, as well as warehousing/storage/distribution records, indicate that the snow peas presented for destruction are not the original product. In addition, some of the snow peas presented have calyx (pieces of stems and leaves) mixed in with the snow peas, which (calyx) are not declared in the original entries. Our examination of the snow peas referenced above and presented for destruction indicate that these snow peas do not appear to be the products which were originally entered.
As a result of our findings, we have recommended that the U. S. Customs Service (Customs) require that future entries of food by your firm be held in secured storage.
Secured storage will be under the supervision and direction of Customs, such as in a bonded warehouse. You will be responsible for all costs incurred at secured storage.
In addition, we are requesting Customs to order redelivery of these shipments. We request a response in writing within fifteen (15) working days of receipt of this letter outlining the specific steps you have taken to correct the violation, including an explanation of each step being taken to prevent recurrence. In the event that the product is still available for examination, you should inform Customs and FDA if and when redelivery is accomplished.
Your written reply should be addressed to the Food and Drug Administration, Attention: Paul R. Bagdikian, Compliance Officer, P. O. Box 59-2256, Miami, Florida 33159-2256.
Emma R. Singleton
Director, Florida District